KAT5 and prostate cancer: In fact, it has been shown that downregulation of Tip60 or Tip60-defective mutant decreases AR activation and reduces PSA mRNA levels induced by androgen in LNCaP cells or in androgen-insensitive prostate cancer cells [6,27].